Fulgent Genetics (MEX:FLGT) Current Accrued Expense : MXN383 Mil (As of Jun. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Fulgent Genetics Current Accrued Expense?

Fulgent Genetics's Current Accrued Expense for the quarter that ended in Jun. 2024 was MXN383 Mil.

Fulgent Genetics's quarterly Current Accrued Expense declined from Dec. 2023 (MXN455 Mil) to Mar. 2024 (MXN319 Mil) but then increased from Mar. 2024 (MXN319 Mil) to Jun. 2024 (MXN383 Mil).

Fulgent Genetics's annual Current Accrued Expense increased from Dec. 2021 (MXN363 Mil) to Dec. 2022 (MXN367 Mil) and increased from Dec. 2022 (MXN367 Mil) to Dec. 2023 (MXN455 Mil).

Fulgent Genetics Current Accrued Expense Historical Data

The historical data trend for Fulgent Genetics's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fulgent Genetics Current Accrued Expense Chart

Fulgent Genetics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Current Accrued Expense

Get a 7-Day Free Trial

25.14

168.01

362.87

367.48

454.57

Fulgent Genetics Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Current Accrued Expense	Get a 7-Day Free Trial															381.09	366.34	454.57	319.36	383.29

Fulgent Genetics Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Fulgent Genetics Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Fulgent Genetics's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Fulgent Genetics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Fulgent Genetics Inc (MEX:FLGT) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

FLGT:USA 7F0:Germany

Address

4978 Santa Anita Avenue, Temple City, CA, USA, 91780

Website

https://www.fulgentgenetics.com

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. Genetic testing offers the possibility of early identification of a disease or a genetic predisposition to disease and enhanced disease treatment and prognosis. Fulgent's product portfolio includes Genes & Panels, Known Mutation, Genomic Testing, Hereditary Cancer, Carrier Screening, Tumor Profiling, and Sequencing Service. Its customers are categorized as Insurance; Institutional, which includes hospitals, medical institutions, laboratories, governmental bodies, municipalities, and large corporations; and Patients. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.